期刊文献+

2型糖尿病患者血糖控制水平对血脂及脂蛋白的影响 被引量:6

Effect of the Serum Lipid and Apolipoprotein Profiles on Glycemic Control in Patients with Type 2 Diabetes Mellitus
暂未订购
导出
摘要 目的 评价2型糖尿病患者血糖控制水平对血脂及脂蛋白的影响.方法 随机检测2012年2月~7月就诊的2型糖尿病患者53例,其中男性30例,女性23例,分别检测糖化血红蛋白比率(HbA1c )、C肽(C-P)、三酰甘油(TG)、总胆固醇(CHO)、高密度脂蛋白胆固醇(HDL-C)、载脂蛋白A(ApoA1)、载脂蛋白B(ApoB)及脂蛋白A(LPa);依据HbA1c,C-P水平将其分为Ⅰ(C肽≥0.6 nmol/L及HbA1c比率<6.0%),Ⅱ(C肽≥0.6 nmol/L及HbA1c比率≥6.0%)及Ⅲ(C肽<0.6 nmol/L及HbA1c比率≥6.0%)三组.结果 多元方差分析结果表明:三组间TG(F=4.33,P〈0.05),CHO(F=6.86,P〈0.05),ApoB(F=9.32,P〈0.001)差异均具有统计学意义,而LPa(F=0.53,P〉0.05),ApoA1(F=1.99,P〉0.05),HDL-C(F=5.76,P〉0.05)差异无统计学意义;调整性别、年龄因素,相关分析结果表明:ApoA1与HDL-C(r=0.75,P〈0.001),CHO与ApoB(r=0.78,P〈0.001)分别呈正相关.结论 Lpa是2型糖尿病病情发展的独立风险因素,TG是重要影响因素.HDL-C/CHO优于HDL-C,ApoA1/CHO优于ApoA1. Objective To evaluate the significance of the serum lipid and apolipoprotein profiles on glycemic control in patients with type 2 diabetes mellitus. Methods A total of 53 patients with type 2 diabetes (30 men,23 female) were collected in Loudi First People's Hospital from February to July 2012 by randomly selected, and fasting HbA1c,C-Peptide (C-P), triglycerides (TG), total cholesterol (CHO), high density lipoprotein-C ( HDL-C), apolipoprotein A1 (ApoA1), apolipoprotein B (ApoB) and lipoprotein A (LPa) levels were measured. They were divided into three groups [group I (C-P≥0.6 nmol/L and HbAle ratio〈6.0% ) ,group Ⅱ (C-P≥0.6 nmol/L and HbA1c ratio≥6.0 %), group Ⅲ (C-P〈0.6 nmol/L and HbA1c ratio≥6.0%)] according to C-Peptide and HbA1c levels. Results Multi-variable analyses showed there were a significant differences in TG (F=4. 33,P〈0.05) ,CHO(F=6.86 ,P〈0.05) ,ApoB (F=9.32 ,P〈0. 001) among three groups. However, there were no significant differences in LPa (F= 0. 53, P〉 0.05), ApoA1 (F = 1.99, P〉 0.05 ), HDL-C ( F = 5.76, P 〉0.05) among three groups. Highly significant positive correlations were observed between ApoA1 and HDL-C levels (r= 0.75, P〈0. 001) adjusted sex and age. Similarly,CHO and ApoB levels (r= 0.78, P〈0. 001) displayed a significant positive correlation. Conclusion Lpa is an independent risk factor influencing on the progression of disease with type 2 diabetes mel- litus,and the TG is an important risk factor. HDL-C/CHO ratio is a more appropriate marker of risk than HDL-C levels,and ApoA1/CHO ratio is a more appropriate marker of risk than ApoA1 levels.
出处 《现代检验医学杂志》 CAS 2013年第1期92-94,共3页 Journal of Modern Laboratory Medicine
关键词 2型糖尿病 脂类 C-肽 糖化血红蛋白 type 2 diabetes lipid profile C-Peptide HbA1c
  • 相关文献

参考文献7

  • 1Lippi G,Targher G,Salvagno GL,et al.Lipoprotein(a) and Ageing[J].Clinical Laboratory,2010,56(9/10):463-466.
  • 2潘洁敏,包玉倩,张磊,张扬,于浩泳,贾伟平.住院2型糖尿病患者血清脂蛋白(a)水平及与糖尿病肾病的关系[J].中华糖尿病杂志,2009,1(3). 被引量:1
  • 3Song KH,Ko SH,Kim HW,et al.Prospective study of lipoprotein(a) as a risk factor for deteriorating renal function in type 2 diabetic patients with overt proteinuria[J].Diabetes care,2005,28(7):1718-1723.
  • 4Kontush A,Chapman MJ.Functionally defective high-density lipoprotein:a new therapeutic target at the crossroads of dyslipidemia,inflammation,and atherosclerosis[J].Pharmacol Rev,2006,58(3):342-374.
  • 5Terasaka N,Wang N,Yvan-Charvet L,et al.High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1[J].Proc Natl Acad Sci USA,2007,104(38):15093-15098.
  • 6Vaverkova H,Karasek D,Novotny D,et al.Apolipoprotein B versus LDL-cholesterol:Association with other risk factors for atherosclerosis[J].Clin Biochem,2009,42(12):1246-1251.
  • 7Schmidt C,Wikstrand J.High apoB/apoA-I ratio is associated with increased progression rate of carotid artery intima-media thickness in clinically healthy 58-year-old men:experiences from very long-term follow-up in the AIR study[J].Atherosclerosis,2009,205(1):284-289.

二级参考文献15

  • 1Ariyo AA,Thach C,Tracy R. Lp (a) lipoprotein,vascular disease,and mortality in the elderly[J].New England Journal of Medicine,2003.2108-2115.
  • 2Gazzaruso C,Garzaniti A,Falcone C. Association of lipoprotein (a) levels and apolipoprotein (a) phenotypes with coronary artery disease in type 2 diabetic patients and in nondiabetic subjects[J].Diabetic Medicine,2001.589-594.
  • 3Cooper ME,Jandeleit Dahm KA. Lipids and diabetic renal disease[J].Current Diabetes Reports,2005.445-448.
  • 4Song KH,Ko SH,Kim HW. Prospective study of lipoprotein(a) as a risk factor for deteriorating renal function in type 2 diabetic patients with overt proteinuria[J].Diabetes Care,2005.1718-1723.
  • 5Mogensen CE. Natural history of renal functional abnormalities in human diabetes mellittts[A].New York:Livingstone,1989.9.
  • 6Krolewski AS,Warram JH,Christliab AR. Hypercholesterolemia:a dctrminant of renal function loss and deaths in IDDM patients with nephropathy[J].Kidney International.Supplement,1994.S125-S131.
  • 7Ravid M,Neumann L,Lishner M. Plasma lipids and the progression of nephropathy in diabetes mellitus type Ⅱ:effect of ACE inhibitors[J].Kidney International,1995.907-910.
  • 8Fried LF,Orchard TJ,Kasiske BL. Effect of lipid reduction on the progression of renal disease:a meta-analysis[J].Kidney International,2001,(1):260-269.doi:10.1046/j.1523-1755.2001.00487.x.
  • 9Boemi M,Sirolla C,Fumelli P. Renal disease as a determinant of increased lipoprotein(a) concentrations in diabetic patients[J].Diabetes Care,1999.2033-2036.
  • 10Kronenberg F,Utermaun G,Dieplinger H. Lipoprotein(a) in renal disease[J].American Journal of Kidney Disease,1996.1-25.

同被引文献38

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部